MicroRNA‐200b is a potential biomarker of the expression of PD‐L1 in patients with lung cancer

類似資料

• MicroRNA‐200b is a potential biomarker of the expression of PD‐L1 in patients with lung cancer
  著者:: Katakura, Seigo, 等
  出版事項: (2020)
• Class A CpG oligodeoxynucleotide inhibits IFN‐γ‐induced signaling and apoptosis in lung cancer
  著者:: Teranishi, Shuhei, 等
  出版事項: (2020)
• Afatinib + bevacizumab combination therapy in EGFR‐mutant NSCLC patients with osimertinib resistance: Protocol of an open‐label, phase II, multicenter, single‐arm trial
  著者:: Nobuaki Kobayashi, 等
  出版事項: (2020-08-01)
• T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer
  著者:: Kamimaki, Chisato, 等
  出版事項: (2021)
• Afatinib + bevacizumab combination therapy in EGFR‐mutant NSCLC patients with osimertinib resistance: Protocol of an open‐label, phase II, multicenter, single‐arm trial
  著者:: Kobayashi, Nobuaki, 等
  出版事項: (2020)